Purchase Order W81K0022P0237
Award Date
10/1/22
Potential Completion Date
9/30/27
Potential Value
$841K
Federal Agency
Medical Command
Awardee
Asuragen Incorporated
Ultimate Awardee
Bio-Techne Corporation
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Asuragen Incorporated, a small business. The contract is for the development and supply of a BCR-ABL 1 RT-QPCR test to improve monitoring of chronic myeloid leukemia (CML). This is a Phase II Small Business Innovation Research (SBIR) contract with a ceiling value of $1,489,494.00. The contract is a definitive contract with a cost-plus-fixed-fee pricing...
This federal contract award, with an ID of 75D30123P15844, was issued by the Centers for Disease Control and Prevention (CDC) to Asuragen Incorporated, a molecular diagnostics company. The $75,075.00 firm fixed-price purchase order is for ARMORED RNA products, which are reagents and testing materials compatible with specialized medical equipment used for cancer and leukemia testing at government healthcare facilities. Asuragen, a subsidiary of the life sciences company Bio-Techne Corporation,...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) component of the Department of Defense to Immucor Inc., a manufacturer of in vitro diagnostic products and reagents. The $187,452.19 contract is for the delivery of molecular BeadChip reagents compatible with the BioArray Array Imaging System (AIS 400) and BioArray Solutions Information System Software (BASIS) to support blood typing and screening operations at the Brooke Army Medical Center in Fort Sam...
The U.S. Department of the Army Medical Command awarded a $247,438.60 firm fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer, for the identification and susceptibility testing of microbes at the Brooke Army Medical Center in JBSA Fort Sam Houston, Texas. The contract does not have a set-aside designation. The original solicitation, W81K00-21-Q-0068, was issued by the Regional Health Contracting Office-Central, seeking reagents compatible with Biomerieux's...
This firm-fixed-price purchase order contract, valued at $269,200.00, was awarded to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, by the U.S. Army Medical Command (MEDCOM). The contract, identified as W81XWH16P0243, is for the delivery of MYBAITS-1-768-B DNA reagents. Biodiscovery LLC is a foreign-owned, for-profit manufacturer specializing in custom molecular biology and synthetic biology solutions, including next-generation sequencing, cytogenomics, and cell-free protein...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the supply of reagents for the GeneXpert Infinity Analyzer equipment. The contract, valued at $1,088,336.70, was awarded by the Department of the Army Medical Command and has a period of performance from October 1, 2018 to September 30, 2021. The contract is a firm-fixed-price purchase order without a set-aside designation. The original solicitation was a Sources Sought notice issued by...
This is a $4,643,559.40 firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Biofire Diagnostics LLC for respiratory, gastrointestinal, meningitis, and blood culture identification assay panels for the Department of Pathology and Area Laboratory Services at Brooke Army Medical Center in Texas. The original pre-solicitation notice sought potential sources to provide multiplex PCR diagnostic equipment, reagents, consumables, and services for pathogenic...
This federal contract award, with a ceiling value of $143,137.40, was issued by the Defense Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is for the delivery of reagents for fiscal year 2016 and does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, is the prime contractor and provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the...
This federal contract award, W81XWH15P0273, was made by the U.S. Army Medical Command (MEDCOM) to Qiagen, LLC, a division of Qiagen N.V., a provider of sample and assay technologies. The contract is for an Interagency Purchase Agreement (IPA) including advanced analytical services. The award is set aside for small businesses, has a firm fixed price of $94,136.20, and a completion date of June 25, 2020. Qiagen has provided products and services to support federal agencies' biomedical research,...
The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Qiagen, LLC, a division of the international medical diagnostics company Qiagen N.V. The contract, valued at $80,457.60, is for the supply of various QIAGEN laboratory supplies including DNA/RNA extraction kits, PCR reagents, and related equipment. This contract was awarded under an unrestricted solicitation and did not have a set-aside designation. Qiagen, as a manufacturer of these specialized...